Group 1 - The first extraordinary general meeting of shareholders for 2025 was held on December 23, 2025, in Beijing, with no resolutions being rejected [2] - The meeting was convened by the board of directors and chaired by Chairman Dan Tie, utilizing a combination of on-site and online voting methods, compliant with the Company Law and Articles of Association [2][3] - All current directors (8) attended the meeting, while 4 out of 5 supervisors were present, with the board secretary and financial director also in attendance [3] Group 2 - The meeting approved several proposals, including the change of the company's registered address and amendments to the Articles of Association and various governance rules [4][5] - The proposal to reappoint the accounting firm was also approved, with separate voting conducted for minority investors [5] Group 3 - The legal firm King & Wood Mallesons witnessed the meeting, confirming that the procedures followed were in accordance with relevant laws and regulations [6] - The meeting's voting procedures and results were deemed legal and valid by the witnessing lawyers [6] Group 4 - Director Zhang Rongxiang resigned due to reaching retirement age, effective immediately upon submission of the resignation letter [10] - The company held an employee representative meeting to elect Peng Liye as the employee representative director, maintaining the board's compliance with legal requirements [12][14]

Group 1 - The company held its first extraordinary general meeting of shareholders on December 23, 2025, with all resolutions passed without any objections [2][5] - The meeting was conducted in compliance with the Company Law and the company's articles of association, utilizing both in-person and online voting methods [2][4] - All seven current directors and three supervisors attended the meeting, along with the board secretary [3] Group 2 - The meeting approved a resolution to change the company's registered capital, abolish the supervisory board, and amend the articles of association [4] - All resolutions discussed at the meeting were special resolutions and received more than two-thirds of the voting rights from attending shareholders [5] - The legal opinion from Beijing DeHeng Law Offices confirmed that the meeting's procedures and resolutions were in accordance with relevant laws and regulations [6] Group 3 - The company announced the cancellation of 9,136,891 repurchased shares, resulting in a corresponding reduction in registered capital by the same amount [9][10] - Creditors are notified to claim their debts within 30 days of receiving the notice or 45 days from the announcement date if no notice is received [10] - Required documentation for creditors includes contracts and proof of debt, with specific instructions for both corporate and individual creditors [11]

Group 1 - The company held its fifth temporary board meeting of the 11th session on December 22, 2025, with all 9 directors present, confirming compliance with legal and regulatory requirements [2] - The board approved several proposals unanimously, including amendments to the General Manager's Office Meeting Rules, the Board Secretary Work System, and the Information Disclosure Management System [3][4] - The board also approved the establishment of a temporary and exemption management system for information disclosure and agreed to extend the operational period of the Everbright Wealth Medical Fund until January 30, 2028, along with signing a supplementary agreement [4]

Group 1 - The fourth extraordinary general meeting of shareholders was held on December 22, 2025, with no resolutions rejected [2] - The meeting was conducted in accordance with the Company Law and the company's articles of association, utilizing both on-site and online voting methods [2][3] - All directors, supervisors, and the board secretary attended the meeting, ensuring full representation [3] Group 2 - Several governance-related proposals were approved, including the cancellation of the supervisory board and amendments to the company's articles of association [4][5] - The meeting passed various resolutions regarding the revision of corporate governance systems, including rules for shareholder meetings and board meetings [5][6] Group 3 - The company announced a guarantee provided by its wholly-owned subsidiaries and actual controller for a total amount of RMB 50 million, with the guarantee exceeding previously approved limits [10][12] - The total amount of external guarantees by the company and its subsidiaries reached RMB 1.765 billion, which is 176.84% of the latest audited net assets attributable to the parent company [11][21] - The guarantees are aimed at supporting the operational needs of the subsidiary Guangdong Bangbao Yizhi Toys Co., Ltd., with the actual controller providing unconditional guarantees [12][21]

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 一、会议召开情况 （一）会议召开时间 1、会议召开时间：2025年12月18日（星期四）14:00。 2、网络投票时间：2025年12月18日。其中，通过深圳证券交易所交易系统进行网络投票的具体时间 为：2025年12月18日9:15-9:25、9:30-11:30、13:00-15:00；通过深圳证券交易所互联网投票系统投票的 具体时间为：2025年12月18日9:15-15:00。 （二）会议召开地点：江西省吉安市吉州区君华大道212号5楼会议室 （三）会议召开方式：本次股东会采取现场投票和网络投票相结合的方式 （四）会议召集人：公司董事会 二、会议出席情况 （一）股东出席的总体情况 通过现场和网络投票的股东292人，代表股份207,444,822股，占公司有表决权股份总数的49.3596%。 （截至股权登记日公司总股本为423,352,124股，其中公司回购专户中的股份数量为3,079,900股，回购股 份不享有表决权，故本次股东会享有表决权的总股本数为股4 ...

Group 1 - The company, Dongrui Food Group Co., Ltd., will hold its first extraordinary general meeting of shareholders for 2026 on January 7, 2026 [2][3] - The meeting will be convened by the board of directors and is compliant with relevant laws and regulations [2][4] - The meeting will adopt a combination of on-site voting and online voting [4][5] Group 2 - The registration date for shareholders to attend the meeting is December 31, 2025 [6] - Shareholders or their proxies who hold shares on the registration date are entitled to attend the meeting [6][7] - The meeting will take place at the company's conference room located in the Biyun Industrial City, Xiantang Town, Dongyuan County, Guangdong Province [8] Group 3 - The meeting will review several proposals, including amendments to the company's articles of association and governance rules [8][31] - Proposals affecting minority investors will require separate voting and disclosure [8][31] - The meeting will also discuss the reappointment of the auditing firm for the year 2025 [43] Group 4 - The board of directors has approved a credit limit of up to 3.8 billion RMB for 2026 to ensure sufficient operational and investment funds [83] - The credit limit includes various financing types such as working capital loans and construction project loans [83] - The board has authorized specific executives to represent the company in signing relevant agreements within the approved credit limit [83]

Group 1 - The first extraordinary general meeting of shareholders for Shenzhen Pumen Technology Co., Ltd. was held on December 16, 2025, at the company's headquarters in Shenzhen [2] - All resolutions proposed during the meeting were approved, with no rejected proposals [2] - The meeting was convened by the board of directors and chaired by Chairman Liu Xiancheng, following legal and procedural requirements [2][3] Group 2 - The meeting included the attendance of all 9 current directors and 3 supervisors, along with the board secretary and senior management [3] - Several governance-related proposals were passed, including the cancellation of the supervisory board and amendments to the company's articles of association and related rules [4][5] - A proposal for the company to apply for a comprehensive credit limit from banks for the year 2026 was also approved [5] Group 3 - The company recently received two medical device registration certificates for in vitro diagnostic reagents from the Guangdong Provincial Drug Administration [9] - The registered products are composite quality control products that ensure the safety and effectiveness of the company's electrochemical luminescence detection system [9] - As of the announcement date, the company and its subsidiaries have obtained a total of 105 registration certificates for electrochemical luminescence detection reagents, enhancing its product competitiveness in the immunodiagnostic field [9]

证券代码：600433 证券简称：冠豪高新 公告编号：2025-050 广东冠豪高新技术股份有限公司 第九届董事会第十一次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 广东冠豪高新技术股份有限公司（以下简称"公司"）第九届董事会第十一次会议于2025年12月15日以现 场结合通讯方式召开。会议通知及会议材料于2025年12月8日以电子邮件方式送达各位董事。会议应参 加董事7人，实际参加董事7人，会议通知和召开程序符合《公司法》及《公司章程》的有关规定，本次 会议由公司董事长李飞先生主持。 二、董事会会议审议情况 （一）董事会以 7 票同意、 0 票反对、 0 票弃权审议通过了《关于调整公司组织架构的议案》 为建立科学高效的运营管控体系，进一步压减管理层级，切实提升公司组织效能与管理效率，拟对公司 组织架构进行整合优化：公司总部和湛江基地管理层合并；成立生产管理中心；整合优化安环、运营、 综合事务、技术中心和仓储部的职能，纪检室更名为纪委办公室，党委巡察办公室更名为巡察办公室； 以上调整有 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002501 证券简称：利源股份 公告编号：2025-085 根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司章程指引》《深圳证券交易所股 票上市规则》《关于新〈公司法〉配套制度规则实施相关过渡期安排》等法律、行政法规、规范性文件 的相关规定，结合公司自身实际情况，拟调整公司治理结构，公司将不再设置监事会，对《公司章程》 《股东大会议事规则》《董事会议事规则》等14项制度进行修订。 修订《公司章程》事项经公司股东大会审议通过后，公司不再设置监事会及监事岗位，公司《监事会议 事规则》等监事会相关制度相应废止，公司各项制度中涉及监事会、监事的规定不再适用，由公司董事 会审计委员会行使《公司法》等相关法律法规中规定的监事会职权。 在公司股东大会审议通过前，公司第六届监事会将严格按照相关法律法规和规范性文件的要求，勤勉尽 责履行监督职能，维护公司和全体股东的利益。 因变更《公司章程》需办理变更登记，同时提请股东大会授权公司管理层向市场监督管理部门办理变更 登记等相关事项。 本次修订涉及的公司治理制度，具体如下表： ■ 吉林利源精制股份有限公司关 ...

证券代码：600956 证券简称：新天绿能 公告编号：2025-070 2025年12月10日 证券代码：600956 证券简称：新天绿能 公告编号：2025-069 新天绿色能源股份有限公司 关于修订或废止公司部分治理制度的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 新天绿色能源股份有限公司（以下简称"公司"）于2025年12月10日召开第六届董事会第三次会议，审议 通过了《关于修订〈新天绿色能源股份有限公司对外担保管理制度〉的议案》《关于修订〈新天绿色能 源股份有限公司独立董事工作制度〉的议案》及《关于修订或废止本公司部分治理制度的议案》。现将 有关情况公告如下： 为提高公司治理水平，进一步完善公司治理制度，根据《中华人民共和国公司法》《上市公司章程指 引》《上市公司独立董事管理办法》《上海证券交易所股票上市规则》《上市公司监管指引第8号一一 上市公司资金往来、对外担保的监管要求》等法律法规、规范性文件的最新规定，结合公司的实际情 况，公司对以下内部治理制度进行了系统性的梳理，拟分别进行修订或废止，具体如下： ■ ...